Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Moderna's mResvia Received A Positive Opinion From The CHMP For Prevention In Adults 60 Years Of Age And Older Of Lower Respiratory Tract Disease And Acute Respiratory Disease Caused By Respiratory Syncytial Virus

Author: Benzinga Newsdesk | June 28, 2024 06:58am

Posted In: MRNA VGK